BioSym: A Theoretical Framework for Photosynthetic Symbiotic Assistant Blood Cells as a Platform for Endogenous Human Enhancement

BioSym, a speculative theoretical framework for the design of a novel class of endogenous biological agents, Photosynthetic Symbiotic Assistant Cells (PSACs); intended to function as a fourth blood cell lineage. Inspired by three converging scientific advances: (1) the LEAF photosynthetic membrane technology demonstrated by NUS researchers in 2026 [Xing et al., 2026], (2) the established safety and immune tolerance of probiotic organisms, and (3) current clinical success of hematopoietic stem cell gene therapy, I propose a unified architecture in which light-harvesting biological agents, derived from non-pathogenic bacterial lineages adapted to individual host DNA, are introduced via injection, migrate to bone marrow, and reprogram a subset of hematopoietic stem cells to continuously produce PSACs. These cells, modeled on the lifespan and renewal cycle of erythrocytes, harvest ambient light via transplanted photosynthetic machinery to generate NADPH and ATP, distribute metabolic currency throughout the body, monitor oxidative stress, support accelerated tissue repair, and in advanced iterations interface with external computational systems. I review the existing scientific literature underpinning each component, identify key technical obstacles, and propose a staged research roadmap. This paper is intended as a call to the synthetic biology community to consider directed endosymbiosis deliberately recapitulating the event that gave rise to mitochondria as a viable long-term strategy for human enhancement and therapeutic medicine.